RedHill Biopharma (RDHL) EPS (Basic) (2012 - 2023)
RedHill Biopharma (RDHL) posted quarterly EPS (Basic) of $1.15 for Q2 2023, up 3275340633.19% year-over-year from N/an in Q2 2022, and up 460.57% quarter-over-quarter from -$0.32 in Q1 2023.
RedHill Biopharma (RDHL) EPS (Basic) (2012 - 2023) Analysis & Trends
RedHill Biopharma (RDHL) has reported EPS (Basic) for 12 consecutive years, with $1.15 the latest figure, recorded in Q2 2023.
- In Q2 2023, EPS (Basic) rose 3275340633.19% year-over-year to $1.15; the TTM figure through Dec 2024 stood at $0.0 (up 102.68% YoY), while the FY2025 annual figure was $0.0, up 136.1% from the prior year.
- EPS (Basic) climbed to $1.15 in Q2 2023 per RDHL's latest filing, from -$0.32 in the prior quarter.
- Across five years, EPS (Basic) topped out at $6.4 million in Q1 2022 and bottomed at -$305.63 in Q4 2021.
- Historically, EPS (Basic) has averaged $353611.8 across 5 years, with a median of $28.12 in 2020.
- Annual changes were most pronounced in 2019 — EPS (Basic) surged 21254592990.27% — and 2021, when it plunged 1156.69%.
- RedHill Biopharma's EPS (Basic) stood at $39.87 in 2019, then fell by 27.45% to $28.92 in 2020, then slumped by 1156.69% to -$305.63 in 2021, then jumped by 99.08% to -$2.81 in 2022, then soared by 141.07% to $1.15 in 2023.
- Business Quant data shows RDHL's EPS (Basic) at $1.15 in Q2 2023, -$0.32 in Q1 2023, and -$2.81 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.15 |
| Mar 31, 2023 | -0.32 |
| Dec 31, 2022 | -2.81 |
| Sep 30, 2022 | -37.81 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 6.37 Mn |
| Dec 31, 2021 | -305.63 |
| Sep 30, 2021 | 28.66 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 36.90 |
| Dec 31, 2020 | 28.92 |
| Sep 30, 2020 | 27.57 |
| Jun 30, 2020 | 25.03 |
| Mar 31, 2020 | 55.39 |
| Dec 31, 2019 | 39.87 |
| Sep 30, 2019 | 36.03 |
| Jun 30, 2019 | 49.79 |
| Mar 31, 2019 | 30.16 |
| Dec 31, 2018 | 53.64 |
| Sep 30, 2018 | 42.57 |